Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up

Published 2017 View Full Article

Authors

Keywords

Renal transplantation, Rabbit antithymocyte globulin, Daclizumab, Alemtuzumab, Tacrolimus, Enteric-coated mycophenolate sodium, Steroid avoidance, Biopsy-proven acute rejection, Graft survival

Journal

TRANSPLANT IMMUNOLOGY

Volume 40, Issue -, Pages 42-50

Publisher

Elsevier BV

Online

2016-11-23

DOI

10.1016/j.trim.2016.11.004

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started